BiotechTube

latanoprost/timolol

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Eye Diseases

Conditions

Eye Diseases, Glaucoma, Open-Angle, Glaucoma

Trial Timeline

May 1, 2009 → Sep 1, 2012

NCT ID
NCT00913029

About latanoprost/timolol

latanoprost/timolol is a approved stage product being developed by Glaukos for Eye Diseases. The current trial status is completed. This product is registered under clinical trial identifier NCT00913029. Target conditions include Eye Diseases, Glaucoma, Open-Angle, Glaucoma.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00913029ApprovedCompleted

Competing Products

20 competing products in Eye Diseases

See all competitors
ProductCompanyStageHype Score
raloxifene + placeboEli LillyPhase 3
77
LatozinemabAlectorPhase 3
69
RLYB116 for InjectionRallybioPhase 1
25
Prasugrel (CS-747) + ClopidogrelEli LillyPhase 2
52
Infliximab + Infliximab + InfliximabCelltrionApproved
85
CT-P13CelltrionPhase 3
77
Subcutaneous infliximab CT-P13 Remsima®SCCelltrionPre-clinical
23
Lesigercept + PlaceboYuhanPhase 2
52
Efficacy and safety of combination therapy of moderate-intensity statin and ezetimibe compared to high-intensity statinYuhanApproved
85
Sarpogrelate SR + SarpogrelateYuhanApproved
85
Prasugrel (Crushed tablets) + Prasugrel (Integral tablets)Daiichi SankyoApproved
85
Mirabegron + Solifenacin succinate + PlaceboAstellas PharmaPhase 2
52
Mirabegron + Solifenacin succinateAstellas PharmaPhase 3
77
ATG (Fresenius Biotech)Astellas PharmaPhase 2
52
TamuslosinAstellas PharmaPhase 3
77
LexiscanAstellas PharmaPhase 2
52
mirabegron 25 mg + mirabegron 50 mg + solifenacin 5 mg + solifenacin 10 mg + mirabegron 25 mg matching placebo + mirabegron 50 mg matching placebo + solifenacin 5 mg matching placebo + solifenacin 10 mg matching placeboAstellas PharmaPhase 3
77
Tacrolimus + Cyclosporine + Mycophenolate mofetil + Methylprednisolone + PrednisoneAstellas PharmaPhase 3
77
TamusulosinAstellas PharmaPhase 3
77
Regadenoson + PlaceboAstellas PharmaApproved
85

Other Products from Glaukos

TravoprostApproved
82
TravoprostApproved
82
Riboflavin 5'-PhosphateApproved
82
iDose TR (Travoprost intracameral Implant) 75mcgApproved
82
Topical travoprost + Tobramycin + DexamethasoneApproved
82